<http://www.biospectrumAsia.com/images/NewsLetter/top1_left.gif>
September 29, 2007
<http://www.biospectrumAsia.com/images/NewsLetter/top1_big.gif> <http://www.biospectrumAsia.com/images/NewsLetter/top1_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top2_left.gif>
<http://www.biospectrumAsia.com/Home.asp> <http://www.myciol.com/mailblaster/click.asp?nl=7_195913_Sep28&adUrl=htt p://www.systat.com/downloads/?sec=d008>
<http://www.biospectrumAsia.com/images/NewsLetter/top6_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top4_left.gif>
www.biospectrumasia.com <http://www.biospectrumAsia.com/Home.asp> <http://www.biospectrumAsia.com/images/NewsLetter/top4_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top5_left.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top6_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top5_left.gif>
<http://www.biospectrumAsia.com/Home/Pharma_Home.asp> <http://www.biospectrumAsia.com/Home/Biotech_Home.asp> <http://www.biospectrumAsia.com/Home/Medtech_Home.asp> <http://www.biospectrumAsia.com/images/NewsLetter/top2_big2.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top6_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top7_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top8_left.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top8_left2.gif> <http://www.biospectrumAsia.com/images/NewsLetter/top8_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top9_left.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/Icon-Today's-news.gif> <http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif> <http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
Dr Jeremy Levin has joined pharmaceutical major Bristol-Myers Squibb's
Research and Development organization as Senior Vice President, External
Science, Technology and Licensing
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/devider_line1.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bul1.gif> Caraco
receives USFDA approval for Methimazole
<http://www.biospectrumAsia.com/Content/270907OTH4436.asp?nl=7_195913_Se
p28> <http://www.biospectrumAsia.com/images/Newsletter/arrow1.gif>
Sun Pharma's US subsidiary, Caraco Pharmaceutical Laboratories has
received final approval from USFDA for its Abbreviated New Drug
Application (ANDA) for Methimazole Tablets
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/devider_line1.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bul1.gif>
NeuroAid set for clinical trials in Singapore, Philippines
<http://www.biospectrumAsia.com/Content/270907SGP4433.asp?nl=7_195913_Se
p28> <http://www.biospectrumAsia.com/images/Newsletter/arrow1.gif>
NeuroAid, a Traditional Chinese Medicine (TCM) to aid stroke recovery,
is set to undergo the largest clinical trial ever conducted on a stroke
recovery medication in Singapore and Philippines
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/devider_line1.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bul1.gif> Taisho,
BrainCells to co-develop CNS drug candidates
<http://www.biospectrumAsia.com/Content/280907JPN4440.asp?nl=7_195913_Se
p28> <http://www.biospectrumAsia.com/images/Newsletter/arrow1.gif>
Taisho has granted exclusive rights to BrainCells for the development and commercialization of compounds for the central nervous system
<http://Biospectrumasia.com/Images/NewsLetter/devider_line1.gif>
<http://www.biospectrumasia.com/bs_registration.asp>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/devider_line1.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
Email to Editorial Team <mailto:bsaedit(*)cybermedia.co.in> | Advertise with BioSpectrum <http://www.biospectrumasia.com/output/index.html>
About BioSpectrum <http://www.biospectrumAsia.com/bs_about.asp> |
Contact Us <http://www.biospectrumAsia.com/bs_contact.asp> |
Unsubscribe
<http://myciol.com/mailblaster/unsubscribe.asp?user=Neethi.s(*)testcompany
.com&nl=BioSpectrum_Asia>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/top9_left2.gif>
MUST READ
<http://www.biospectrumAsia.com/images/NewsLetter/bul1.gif> Eisai
establishes new marketing subsidiary in Belgium
<http://www.biospectrumAsia.com/Content/280907JPN4438.asp?nl=7_195913_Se
p28> <http://www.biospectrumAsia.com/images/Newsletter/arrow1.gif>
Eisai has established its pharmaceutical marketing subsidiary, Eisai
SA/NV in Belgium
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/devider_line2.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/spacer.gif>
<http://www.ibclifesciences.com/india/5439.xml>
<http://www.biospectrumasia.com/UserFiles/Image/148x130-(11kb)-
newsletter box ad.gif>
<http://www.myciol.com/mailblaster/click.asp?nl=7_195913_Sep28&adUrl=htt p://www.selectbiosciences.com/>
<http://www.biospectrumAsia.com/images/NewsLetter/top9_right.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bot_left.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bot_mid.gif>
<http://www.biospectrumAsia.com/images/NewsLetter/bot_right.gif>
<http://www.myciol.com/mailblaster/click.asp?nl=7_195913_Sep28&user=Neet hi.s(*)testcompany.com> Received on Fri Sep 28 2007 - 17:53:26 EDT
|
|
